Home LiteratureArticle Details
PMID: 9732345 Published · ppublish English Journal Article Review

Ductal carcinoma in situ of the breast.

BMJ (Clinical research ed.) ·Vol. 317 ·No. 7160 ·1998-09-12 ·Pages 734-9

Silverstein MJ

Abstract

暂无摘要

MeSH Terms
Breast Neoplasms/diagnosis,therapy Carcinoma in Situ/diagnosis,therapy Carcinoma, Ductal, Breast/diagnosis,therapy Clinical Protocols Female Humans Mastectomy/methods Neoplasm Recurrence, Local Prognosis Survival Rate Treatment Outcome
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Silverstein M J
The Breast Center, 14624 Sherman Way, Van Nuys, CA 91405, USA. melsilver9@aol.com
References (26)
26 references, click to expand
  1. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence.
    Cancer. 1989 Feb 15;63(4):618-24 PMID: 2536582
  2. Axillary lymph node dissection for intraductal breast carcinoma--is it indicated?
    Cancer. 1987 May 15;59(10):1819-24 PMID: 3030529
  3. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons.
    Cancer. 1980 Jun 15;45(12):2917-24 PMID: 7388735
  4. Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p.
    J Clin Pathol. 1995 Jul;48(7):611-5 PMID: 7560165
  5. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast.
    Eur J Cancer. 1995;31A(9):1425-7 PMID: 7577065
  6. Allelic loss and the progression of breast cancer.
    Cancer Res. 1995 Nov 15;55(22):5180-3 PMID: 7585569
  7. Improved axillary staging of breast cancer with sentinel lymphadenectomy.
    Ann Surg. 1995 Sep;222(3):394-9; discussion 399-401 PMID: 7677468
  8. Prognostic classification of breast ductal carcinoma-in-situ.
    Lancet. 1995 May 6;345(8958):1154-7 PMID: 7723550
  9. Loss of heterozygosity in ductal carcinoma in situ of the breast.
    J Pathol. 1995 Feb;175(2):195-201 PMID: 7738715
  10. Pathologic analysis of the National Surgical Adjuvant Breast Project (NSABP) B-17 Trial. Unanswered questions remaining unanswered considering current concepts of ductal carcinoma in situ.
    Cancer. 1995 Mar 15;75(6):1219-22; discussion 1223-7 PMID: 7882273
  11. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). The National Surgical Adjuvant Breast and Bowel Project Collaborating Investigators.
    Cancer. 1995 Mar 15;75(6):1310-9 PMID: 7882281
  12. Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast.
    Int J Radiat Oncol Biol Phys. 1994 Aug 30;30(1):3-9 PMID: 8083125
  13. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe.
    Surg Oncol. 1993 Dec;2(6):335-9; discussion 340 PMID: 8130940
  14. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer.
    N Engl J Med. 1993 Jun 3;328(22):1581-6 PMID: 8292119
  15. Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization.
    Hum Pathol. 1993 Jan;24(1):16-23 PMID: 8380275
  16. Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment.
    Cancer. 1993 Apr 15;71(8):2532-42 PMID: 8384070
  17. Radiation therapy for in situ or localized breast cancer.
    N Engl J Med. 1993 Nov 18;329(21):1577-8; author reply 1578 PMID: 8413484
  18. Genetic divergence in the clonal evolution of breast cancer.
    Cancer Res. 1996 Apr 1;56(7):1493-7 PMID: 8603391
  19. Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast.
    J Clin Oncol. 1996 Mar;14(3):754-63 PMID: 8622021
  20. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy.
    Cancer. 1995 Oct 1;76(7):1197-200 PMID: 8630897
  21. A prognostic index for ductal carcinoma in situ of the breast.
    Cancer. 1996 Jun 1;77(11):2267-74 PMID: 8635094
  22. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer.
    JAMA. 1996 Dec 11;276(22):1818-22 PMID: 8946902
  23. A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): correlation with grade of associated invasive carcinoma.
    Histopathology. 1996 Nov;29(5):397-409 PMID: 8951484
  24. Cancer statistics, 1998.
    CA Cancer J Clin. 1998 Jan-Feb;48(1):6-29 PMID: 9449931
  25. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.
    J Clin Oncol. 1998 Feb;16(2):441-52 PMID: 9469327
  26. Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast.
    J Clin Oncol. 1998 Apr;16(4):1367-73 PMID: 9552039
Article Info
Journal
BMJ (Clinical research ed.)
Abbr.
BMJ
ISSN
0959-8138
Published
1998-09-12
Pages
734-9
Language
English
Region
England
NLM ID
8900488
PMCID
PMC1113874
Subset
IM
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com